Adenocarcinoma of Lung Stage IV Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Lung adenocarcinoma stage IV / Adenocarcinoma Lung Stage IV / Stage IV Lung Adenocarcinoma / Lung adenocarcinoma metastatic / Adenocarcinoma of lung, stage IV

DBCOND0062752 (Adenocarcinoma of Lung Stage IV)Active Not Recruiting3 IdentifierTitlePurposeDrugs
NCT00946712S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerTreatment